With this simple, all-in-one solution you can create a stunning site with no technical know-how, but could Wix be a bit too simple for you?
AppLovin is a leading online advertising platform, driven by its AXON AI engine and expanding product suite. Learn more about ...
ARE you dreaming of a career change? Then a ‘slashie’ job could be exactly what you’re looking for. ‘Slashies’ have multiple jobs instead of a single career, and ...
Despite the big conferences stocking up on top teams in recent years, some of the biggest games in college football still come between historic rivals outside of the current conference system. That is ...
Climatedepot.com executive editor Marc Morano reacts to President Donald Trump's anti-climate change rhetoric uttered before the United Nations General Assembly Questions swirl around Donald Trump, ...
Let’s take a look at who’s up, who’s down, and whom to watch ahead of the Patriots-Panthers Week 4 matchup on Sunday. Tight end Hunter Henry: Since Drake Maye took over as the starting quarterback in ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. The Supreme Court knocked down one of the ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. In 2007, Chief Justice John Roberts ...
A transphobic man threatened to shoot up an LGBTQ+ bar in Phoenix last Wednesday because he was “triggered” by the recent murder of rightwing YouTuber Charlie Kirk. Police arrested 49-year-old Treven ...
Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...
You’re reading The Financial Page, John Cassidy’s weekly column on economics and politics. If nothing else, the events of recent weeks have been clarifying. “Donald Trump is using the murder of ...
(Reuters) -Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the fast-growing obesity ...